Vitality Biopharma Files Intellectual Property in All Major Pharmaceutical Markets Worldwide
28 mars 2018 08h30 HE
|
Vitality Biopharma, Inc
THC prodrugs including VBX-100 designed to deliver cannabinoids for targeted therapeutic effects without psychoactivity LOS ANGELES, March 28, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc....
Vitality Biopharma CEO Robert Brooke Provides Shareholder Letter
19 mars 2018 08h00 HE
|
Vitality Biopharma, Inc
LOS ANGELES, March 19, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB:VBIO) (“Vitality” or the “Company”) a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals,...
Vitality Biopharma Submits Orphan Drug Designation Request to FDA for Flagship THC Prodrug VITA-100
17 janv. 2018 08h00 HE
|
Vitality Biopharma, Inc
LOS ANGELES, Jan. 17, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB: VBIO) (“Vitality” or the “Company”) a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals,...
Vitality Biopharma Introduces Cannabinoid Pharmaceutical VITA-100 as Prodrug of THC
03 janv. 2018 08h30 HE
|
Vitality Biopharma, Inc
LOS ANGELES, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB:VBIO) (“Vitality” or the “Company”) a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals,...
Vitality Biopharma Completes Pivotal GMP Manufacturing Agreements for Cannabinoid Pharmaceuticals
01 nov. 2017 07h00 HE
|
Vitality Biopharma, Inc.
LOS ANGELES, CA--(Marketwired - Nov 1, 2017) - Vitality Biopharma, Inc. (OTCQB: VBIO) ("Vitality Biopharma," "Vitality," or the "Company") a corporation dedicated to the development of cannabinoid...
Vitality Biopharma Announces Positive Results for Multiple Cannabinoid Drug Formulations in Treatment of IBD
19 oct. 2017 07h00 HE
|
Vitality Biopharma, Inc.
LOS ANGELES, CA--(Marketwired - Oct 19, 2017) - Vitality Biopharma, Inc. (OTCQB: VBIO) ("Vitality" or the "Company"), a corporation dedicated to the development of cannabinoid prodrug...
Vitality Biopharma Announces Publication of International PCT Patent Filing for Cannabinoid Pharmaceuticals
16 oct. 2017 07h00 HE
|
Vitality Biopharma, Inc.
LOS ANGELES, CA--(Marketwired - Oct 16, 2017) - Vitality Biopharma, Inc. (OTCQB: VBIO) ("Vitality" or the "Company") a corporation dedicated to the development of cannabinoid prodrug...
Vitality Biopharma Achieves Cannabinoid Pharmaceutical Biosynthesis Breakthrough
04 oct. 2017 07h30 HE
|
Vitality Biopharma, Inc.
LOS ANGELES, CA--(Marketwired - Oct 4, 2017) - Vitality Biopharma, Inc. (OTCQB: VBIO) ("Vitality Biopharma", "Vitality", or the "Company") a corporation dedicated to the development of cannabinoid...
Vitality Biopharma Receives Updated SeeThruEquity Price Target of $2.40
27 sept. 2017 11h07 HE
|
Vitality Biopharma, Inc.
LOS ANGELES, CA--(Marketwired - Sep 27, 2017) - Vitality Biopharma, Inc. (OTCQB: VBIO) ("Vitality", "Vitality Biopharma", or the "Company") a corporation dedicated to the development of cannabinoid...
Vitality Biopharma to Present at The MoneyShow San Francisco Conference
23 août 2017 08h47 HE
|
Vitality Biopharma, Inc.
LOS ANGELES, CA--(Marketwired - Aug 23, 2017) - Vitality Biopharma, Inc. (OTCQB: VBIO) ("Vitality", "Vitality Biopharma", or the "Company") a corporation dedicated to the development of cannabinoid...